Efficacy Study of Single Stage Breast Reconstruction in Female Participants With Mastectomy (ESSBR)
A Prospective, Multicenter, Controlled Study of Implant-based Breast Reconstruction, Measuring the Safety, Efficacy and Outcomes, of Immediate Single Stage Breast Reconstruction With Strattice™ Reconstructive Tissue Matrix Versus Immediate Two Stage Breast Reconstruction Without Strattice™ TM (ESSBR-Efficacy of Single Stage Breast Reconstruction)
Sponsor: LifeCell
Terminated
The study is being terminated due to no enrollment in over one year in the control arm
This NA trial investigates Mastectomy and Breast Reconstruction and is currently terminated or withdrawn. LifeCell leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2020 [monthly]
Terminated NA
-
Apr 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Apr 2017 [monthly]
Terminated NA
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LifeCell
For direct contact, visit the study record on ClinicalTrials.gov .